Assignee
DAIICHI SANKYO EUROPE GMBH
DE·10 granted patents·1 pending application·10 citations·filing 2013–2022
Top patents by PatentIndex Score
11 records- 0179US2023059353A1Antibodies directed to her-3 and uses thereofDAIICHI SANKYO EUROPE GMBH·Filed 2022·Application pending·0 cites
- 0278US9988462B2Material and methods for treating or preventing HER-3 associated diseasesDAIICHI SANKYO EUROPE GMBH·Filed 2016·Granted Jun 5, 2018·2 cites·31 claims
- 0378US9803025B2Material and methods for treating or preventing HER-3 associated diseasesDAIICHI SANKYO EUROPE GMBH·Filed 2013·Granted Oct 31, 2017·3 cites·38 claims
- 0476US10358498B2Human anti-FGFR4 antibodyDAIICHI SANKYO EUROPE GMBH·Filed 2015·Granted Jul 23, 2019·4 cites·10 claims
- 0570US11267900B2Antibodies directed to HER-3 and uses thereofDAIICHI SANKYO EUROPE GMBH·Filed 2018·Granted Mar 8, 2022·0 cites·12 claims
- 0667US12139549B2Material and methods for treating or preventing HER-3 associated diseasesDAIICHI SANKYO EUROPE GMBH·Filed 2017·Granted Nov 12, 2024·0 cites·20 claims
- 0765US10357566B2HER3 inhibitor for modulating radiosensitivityDAIICHI SANKYO EUROPE GMBH·Filed 2013·Granted Jul 23, 2019·1 cites·21 claims
- 0859US11351259B2HER3 inhibitor for modulating radiosensitivityDAIICHI SANKYO EUROPE GMBH·Filed 2019·Granted Jun 7, 2022·0 cites·23 claims
- 0956US11648310B2Combination of anti-FGFR4-antibody and bile acid sequestrantDAIICHI SANKYO EUROPE GMBH·Filed 2020·Granted May 16, 2023·0 cites·5 claims
- 1051US10765738B2Combination of anti-FGFR4-antibody and bile acid sequestrantDAIICHI SANKYO EUROPE GMBH·Filed 2016·Granted Sep 8, 2020·0 cites·8 claims
- 1144US10995143B2Combination of human anti-FGFR4 antibody and SorafenibDAIICHI SANKYO EUROPE GMBH·Filed 2017·Granted May 4, 2021·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when DAIICHI SANKYO EUROPE GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →